Continuous hyperfractionated accelerated radiotherapy weekend-less (CHARTWEL) in non small-cell lung cancer (NSCLC)

被引：0
|
作者：
Roth, BM
Bonomi, MR
Cerchetti, L
Pogany, C
Zaderajko, M
Brosio, C
机构：
来源：
RADIOLOGY | 2001年 / 221卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：173 / 174
页数：2
相关论文
共 50 条
  • [31] 73.6 Gy and beyond: Hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer
    Maguire, PD
    Marks, LB
    Sibley, GS
    Herndon, JE
    Clough, RW
    Light, KL
    Hernando, ML
    Antoine, PA
    Anscher, MS
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) : 705 - 711
  • [32] INDUCTION CHEMOTHERAPY AND CONTINUOUS HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (CHART) FOR PATIENTS WITH LOCALLY ADVANCED INOPERABLE NON SMALL-CELL LUNG CANCER: THE MRC INCH RANDOMIZED TRIAL
    Hatton, Matthew
    Nankivell, Matthew
    Lyn, Ethan
    Falk, Stephen
    Pugh, Cheryl
    Navani, Neal
    Stephens, Richard
    Parmar, Mahesh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (03): : 712 - 718
  • [33] Routine use of continuous, hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer: A five-center experience
    Din, Omar S.
    Lester, Jason
    Cameron, Alison
    Ironside, Janet
    Gee, Amanda
    Falk, Stephen
    Morgan, Sally A.
    Worvill, Jackie
    Hatton, Mattew Q. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03): : 716 - 722
  • [34] Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer
    Frytak, S
    Shaw, EG
    Jett, JR
    Richardson, RL
    Foote, RL
    Creagan, ET
    Eagan, RT
    Su, JQ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (02): : 193 - 198
  • [35] Treatment of Non-small Cell Lung Cancer (NSCLC) Using Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART): the Weston Park Hospital Experience 2005-2010
    Lester, J. E.
    Das, T.
    Din, O. S.
    Hatton, M. Q.
    CLINICAL ONCOLOGY, 2011, 23 (03) : S43 - S44
  • [36] Survival following treatment of non-small cell lung cancer (NSCLC) using continuous hyperfractionated accelerated radiotherapy (CHART): A single-centre retrospective analysis
    Ayre, G.
    Casswell, G.
    Comins, C.
    Falk, S.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S108 - S109
  • [37] Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer
    Zwitter, Mayaz
    Kovac, Vijem
    Smrdel, Uros
    Strojan, Primoz
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (07) : 662 - 666
  • [38] CHART to CHARTWEL to chemotherapy and CHARTWEL in non-small cell lung cancer
    Lyn, BE
    Wilson, EM
    Williams, FJ
    Saunders, MI
    Phillips, H
    BRITISH JOURNAL OF CANCER, 2003, 88 : S23 - S23
  • [39] CONTINUOUS, HYPERFRACTIONATED, ACCELERATED RADIOTHERAPY (CHART) IN NON-SMALL-CELL CARCINOMA OF THE BRONCHUS
    SAUNDERS, MI
    DISCHE, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (05): : 1211 - 1215
  • [40] Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated vs conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)
    Baumann, M.
    Herrmann, T.
    Koch, R.
    Wahlers, B.
    Kepka, L.
    Marschke, G.
    Feltl, D.
    Fietkau, R.
    Budach, V.
    Dunst, J.
    EJC SUPPLEMENTS, 2009, 7 (03): : 4 - 4
12345